Regulatory Submission in Europe in Absence of Reference product [Regulatives / Guidelines]

posted by drgunasakaran1  – 2021-05-20 09:20 (1299 d 18:21 ago) – Posting: # 22360
Views: 4,435

Dear Abhay Patil,

❝ The Individual product are present in Europe for more than 20 years and their equivalent Generics too available and filed under WEU. so in such case is it necessary to do BABE study


Yes. We need to conduct studies even though equivalent Individual Product Generics are available in the EU Market.

Dr S Gunasakaran MBBS MD
Disclaimer: The replies/posts are my personal opinions and it does not represent my company views on the same.

Complete thread:

UA Flag
Activity
 Admin contact
23,335 posts in 4,901 threads, 1,666 registered users;
31 visitors (0 registered, 31 guests [including 10 identified bots]).
Forum time: 02:42 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5